Fluticasone propionate (Adare Pharmaceuticals)

N/A

Report date: 2025/11/14 13:58:56

Base Information

Drug NameFluticasone propionate (Adare Pharmaceuticals)
Drug Alias NameEUR-1100APT-1011
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsEosinophilic Esophagitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[4
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAptalis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEllodi Pharmaceuticals
Inactive CompaniesForest Laboratories Inc
Active IndicationsEosinophilic Esophagitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A